RLS-1496
- Preclinical topical · GPX4 modulator · Rubedo Life Sciences · sponsor targets H1 2027 for first data from a trial starting Oct 2026 (said Sep 2026)
GPX4-modulating compound aimed at senescent cells; preclinical for hair, with no registered hair trial
Information, not medical advice. Talk to a licensed doctor or pharmacist before starting or changing a treatment.
Research
— no indexed studies mention RLS-1496 in a hair context yet
All on OpenAlex →Posts 7
- Why PP405 may not be dead just yet
- Most Promising Future Hair Loss Treatments In 2026
- PP405 gets its generic name - Suvomipic
- DUTASTERIDE: EOD or Once a Day
- Does PRP therapy actually work?
- Dutasteride Users - How is your Sex life?
- TEVA finasteride 1mg - wanting to hear other's experiences